Skip to content

LABO MÉRILO

Active Risk: moderate
Private limited companyfounded 20242 yrs activePrins Boudewijnlaan 32, 2610 Antwerpen, BelgiumKBO/BCE: BE 1012.823.520
Summary

The computed 12-month bankruptcy probability of LABO MÉRILO is 2.1% (moderate). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Overview

Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21209
1 site
Size
No accounts filed yet
Financial health
Bankruptcy chance 12 m
2.1%
No score: no figures
Structure
0 of 3 deeds read
Signals- Founded in 2024+ Sector Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)Show the evidence

Checked score

Bankruptcy probability, 12 months
2.1% Moderate
0%0.5%1.5%4%10%≥ 25%

About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 1.1% (17 companies)
Last 17 months 09-2025: 1.2%lowest value 10-2025: 1.2%● 0.0% vs 09-2025lowest value 11-2025: 1.3%▲ +2.8% vs 10-2025 12-2025: 1.4%▲ +8.9% vs 11-2025 01-2026: 1.5%▲ +5.7% vs 12-2025 02-2026: 1.7%▲ +11.8% vs 01-2026 03-2026: 1.7%● 0.0% vs 02-2026 04-2026: 1.8%▲ +10.3% vs 03-2026 05-2026: 1.9%▲ +2.0% vs 04-2026 06-2026: 1.8%▼ -4.6% vs 05-2026 07-2026: 1.8%▲ +1.5% vs 06-2026 08-2026: 2.0%▲ +12.9% vs 07-2026 09-2026: 2.1%▲ +1.2% vs 08-2026highest value 10-2026: 2.1%● 0.0% vs 09-2026highest value
  • Founded in 2024 raises the probability for this profile
  • Sector Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21) lowers the probability
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Two signals.
−lowers risk+raises risk
raises risk · Founded in 2024
In the bankruptcy model this factor raises the probability for this profile.
KBO
lowers risk · Sector Manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21)
In the bankruptcy model this factor lowers the probability.
KBO
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Key points

  • Caution: No annual accounts yetat the National Bank 0 View
  • Active since 2024founded 27-08-2024 2 years View

By topic

Company details

Sites
1
Legal form
Private limited company
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21209
Founded
27-08-2024
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.